Evidence map›Paper›PMID 39291215›Full record

ArticleKidney international reports2024

Timing and Modality of Kidney Replacement Therapy in Children and Adolescents.

Julia Thumfart, Steffen Wagner, Marietta Kirchner, Karolis Azukaitis, Aysun K Bayazit, Lukasz Obrycki, Nur Canpolat, Ipek Kaplan Bulut, Ali Duzova, Ali Anarat and 16 more

Abstract read
In one paragraph

Article in Kidney international reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Julia ThumfartDepartment of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin, Berlin, Germany.
Steffen WagnerBHT Berliner Hochschule für Technik, Berlin, Germany.
Marietta KirchnerInstitute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
Karolis AzukaitisClinic of Pediatrics, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
Aysun K BayazitDepartment of Pediatric Nephrology, School of Medicine, Cukurova University, Adana, Türkiye.
Lukasz ObryckiDepartment of Nephrology, Kidney Transplantation and Hypertension, Children`s Memorial Health Institute, Warsaw, Poland.
Nur CanpolatDivision of Pediatric Nephrology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
Ipek Kaplan BulutDepartment of Pediatric Nephrology, Ege University Faculty of Medicine, Izmir, Türkiye.
Ali DuzovaDivision of Pediatric Nephrology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Ali AnaratDepartment of Pediatric Nephrology, School of Medicine, Cukurova University, Adana, Türkiye.
Lucie BessenayHôpital Femme Mère Enfant, Hospices Civils de Lyon, Université de Lyon, Lyon, France.
Rukshana ShroffUCL Great Ormond Street Hospital and Institute of Child Health, London, UK.
Dusan ParipovicDepartment of Pediatric Nephrology, University Children's Hospital, Belgrade, Serbia.
Lale SeverDivision of Pediatric Nephrology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
Cengiz CandanDepartment of Pediatric Nephrology, Istanbul Medeniyet University, Istanbul, Türkiye.
Francesca LuganiDivision of Nephrology and Transplantation, IRCCS Istituto G. Gaslini, Genova, Italy.
Alev YilmazIstanbul University, Istanbul Faculty of Medicine, Istanbul, Türkiye.
Fatos YalcinkayaDepartment of Pediatrics, Ankara University Medical School, Ankara, Türkiye.
Klaus ArbeiterDivision of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Aysel KiyakDepartment of Pediatric Nephrology, Yenimahalle Egitim ve Arastirma Hastanesi Bakirkoy, Istanbul, Türkiye.
Aleksandra ZurowskaDepartment of Pediatric Nephrology, Medical University of Gdansk, Gdansk, Poland.
Matthias GalianoDepartment of Pediatrics and Adolescent Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.
Uwe QuerfeldDepartment of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin, Berlin, Germany.
Anette MelkDepartment of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Franz SchaeferCenter for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
4C Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The choice and timing of kidney replacement therapy (KRT) is influenced by clinical factors, laboratory features, feasibility issues, family preferences, and clinicians' attitudes. We analyzed the factors associated with KRT modality and timing in a multicenter, multinational prospective pediatric cohort study. Methods: A total of 695 pediatric patients with chronic kidney disease (CKD) enrolled into the Cardiovascular Comorbidity in Children with CKD (4C) study at age 6 to 17 years with estimated glomerular filtration rate (eGFR) of 10 to 60 ml/min per 1.73 m Results: During the 8-year observation period, 342 patients (49%) started KRT. Of these, 200 patients started dialysis, whereas 142 patients underwent preemptive Tx. A lower eGFR at enrolment (Hazard ratio [HR]: 0.76 [95% confidence interval: 0.74-0.78]), a steeper eGFR slope (HR: 0.90 [0.85-0.95], and a higher systolic blood pressure SD score (SDS) (HR: 2.07 [1.49-2.87]) increased the likelihood of KRT initiation. Patients with glomerulopathies were more likely to start dialysis than children with congenital anomalies of the kidneys and urinary tracts (CAKUT) (HR: 3.81 [2.52-5.76]). Lower body mass index (BMI) SDS (HR: 0.73 [0.6-0.89]) and lower hemoglobin (HR: 0.8 [0.72-0.9]) were associated with higher likelihood of dialysis. A significant center effect was observed, accounting for 6.8% (dialysis) to 8.7% (preemptive Tx) of explained variation. Conclusion: The timing and choice of KRT in pediatric patients is influenced by the rate of kidney function loss, the underlying kidney disease, nutritional status, blood pressure, anemia and center-specific factors.

Indexed as

dialysis initiationpediatric risk factorsprogression kidney disease

Identifiers

PMID39291215
PMCPMC11403031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.